-The Hindu Business Line MUMBAI: The government on Monday constituted a standing committee headed by Niti Aayog to oversee the drug pricing regime, a move which could clip the powers of drug pricing regulator, National Pharmaceutical Pricing Authority (NPPA). The Standing Committee on Affordable Medicines and Health Products will be headed by NITI Aayog member (health), and includes chief economic adviser, besides secretary department of health research, director general of health...
More »SEARCH RESULT
Total Matching Records found : 943
India's richest 1% get richer by 39% in 2018; just 3% rise for bottom-half: Oxfam
-PTI At Davos, Oxfam said this increasing inequality is undermining the fight against poverty, damaging economies and fuelling public anger across the globe Indian billionaires saw their fortunes swell by Rs. 2,200 crore a day last year, with the top 1 per cent of the country’s richest getting richer by 39 per cent as against just 3 per cent increase in wealth for the bottom-half of the population, an Oxfam study said...
More »No more tax! Medical bills in Kerala likely to come down
-The New Indian Express In a major relief to in-patients, the Kerala High Court on Friday said Medicines, implants and other materials used during procedures at hospitals do not constitute sale and sales tax cannot be levied KOCHI: Medical bills in hospitals across the country are skyrocketing, but Kerala may see a downward trend. In a major relief to in-patients, the Kerala High Court on Friday said Medicines, implants and other...
More »MSP was not 1.5 times the cost of production for most kharif crops during the last 6 agricultural years
In its 2014 election manifesto, the Bharatiya Janata Party (BJP), among other things, promised to "take steps to enhance the profitability in agriculture, by ensuring a minimum of 50% profits over the cost of production". In his 2018-19 Union budget speech too, the Finance Minister Shri Arun Jaitley informed the Parliament that the 2014 election manifesto of the BJP had stated that the farmers should get at least 1.5 times the...
More »Health ministry mulled compulsory licencing of rare disease drugs -Sushmi Dey
-The Times of India NEW DELHI: The health ministry was actively mulling compulsory licensing, apart from price capping, of “orphan drugs” (for rare diseases), when the department of pharmaceuticals abruptly issued an order exempting such Medicines from price control, derailing plans to make these drugs affordable. The health ministry discussed price capping and invoking compulsory licence for these “exorbitantly” priced “orphan drugs” at a meeting on January 3, the day when DoP...
More »
